Biotechnology has been growing exponentially across all segments of the industry. It is estimated that the global market will command $727.1 Billion USD by 2025.
The biotech industry is filled with educated and innovative professionals. And with the stakes in terms of human life and capital investment so high, who better to take control of automation requirements for their industry than the scientists who built the biotech industry?
A key challenge for biotech companies is the progression from research to scale production. There are a number of reasons biotech companies find it challenging to industrialize, but all of them can be overcome with the right automation partner.